Liu et al. examined the expression of VEGF-C in NSCLC patients and showed that lymphovascular density is higher in VEGF-C positive tumors, which means that VEGF-C can affect both tumor growth and the occurrence of lymphnodal metastases [41]. This evidence concerns the gene VEGFC and non-small cell lung carcinoma.